logo

For the Inventor, By the Inventor

Malden, MA, United States of America

N Laxma Reddy

This inventor holds 24 USPTO granted patents, primarily in Pharmaceutical Compounds. Top assignees: Cambridge Neuroscience, Inc., Cambridge Neurosciences, Inc., Cenes Pharmaceuticals, Inc.. Active years: 1994-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: N Laxma Reddy. Retrieved from https://idiyas.com/inventor/n-laxma-reddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24

% Patents Active = 91.7

Average Co-Inventor Count = 7.3

ph-index = 6

Forward Citations = 137(Granted Patents)


Location History:

  • Lexington, MA (US) (2000 - 2004)
  • Malden, MA (US) (1994 - 2008)

Company Filing History:

goldMedal19 out of 43 
 
Cambridge Neuroscience, Inc.
 patents
silverMedal1 out of 1 
 
Cambridge Neurosciences, Inc.
 patent
bronzeMedal1 out of 3 
 
Cenes Pharmaceuticals, Inc.
 patents
4. 1 out of 4 
 
Scion Pharmaceuticals, Inc.
 patents
5. 1 out of 1,309 
 
Wyeth
 patents
6. 1 out of 834,570 
Other
 patents

Years Active: 1994-2008

Loading Chart...
Areas of Expertise:
Therapeutic Guanidines
Pharmaceutically Active Compounds
Nitrogen Ring Compounds
Aminoguanidines
Hydrazinedicarboximidamide
Calcium Channel Antagonists
Substituted Guanidines
Pharmaceutical Composition
Modulators
Substituted Aminoguanidines
Acenaphthyl Substituted Guanidines
Substituted Hydrazines
24 patents (USPTO):Explore Patents
1. 7351743 - Therapeutic guanidines (2008-04-01),
2. 6787569 - Therapeutic guanidines (2004-09-07),
3. 6770668 - Pharmaceutically active compounds and methods of use (2004-08-03),
4. 6514990 - Pharmaceutically active compounds and methods of use (2003-02-04),
5. 6358993 - Pharmaceutically active nitrogen ring compounds and methods of use thereof (2002-03-19),
6. 6288123 - Therapeutic guanidines (2001-09-11),
7. 6174924 - Therapeutic guanidines (2001-01-16),
8. 6143791 - Therapeutic guanidines (2000-11-07),
9. 6071969 - Substituted aminoguanidines and methods of use thereof (2000-06-06),
10. 6025355 - Pharmaceutically active compounds and methods of use (2000-02-15),
11. 5847006 - Therapeutic guanidines (1998-12-08),
12. 5837737 - Hydrazinedicarboximidamide compounds and pharmaceutical composition (1998-11-17),
13. 5741661 - Substituted guanidines and derivatives thereof as modulators of (1998-04-21),
14. 5686495 - Substituted hydrazinedicarboximidamides and methods of use thereof (1997-11-11),
15. 5681861 - Aminoguanidines and methods of use of same (1997-10-28),

Title: N Laxma Reddy: Pioneering Innovations in Therapeutic Guanidines

Introduction

N Laxma Reddy is a renowned inventor based in Malden, MA, USA, recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 24 patents, Reddy's work primarily focuses on therapeutic compounds that hold potential for medicinal applications.

Latest Patents

Among his latest inventions are several patents related to therapeutic guanidines. The present invention provides therapeutically useful substituted guanidines, along with methods of treatment and pharmaceutical compositions that incorporate these innovative guanidines. This work highlights Reddy's commitment to advancing healthcare through his research in therapeutic agents.

Career Highlights

Throughout his career, N Laxma Reddy has made impactful strides in the pharmaceutical sector, working with notable companies such as Cambridge Neuroscience, Inc. and Cambridge Neurosciences, Inc. His contributions in these roles have been instrumental in developing new treatments that can significantly improve patient outcomes.

Collaborations

Reddy has collaborated with esteemed professionals in his field, including Stanley M Goldin and Subbarao Katragadda. These collaborations have likely aided his research efforts and contributed to the overall success of his innovative projects.

Conclusion

N Laxma Reddy continues to exemplify the spirit of innovation through his extensive work in developing therapeutic guanidines. With a strong foundation in research and a dedication to improving therapeutic options, Reddy remains a pivotal figure in the biotechnology and pharmaceutical industries.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…